MetaADEDB 2.0 @ LMMD
Loratadine and pseudoephedrine sulfate
(KBYGOCNIUHCOLP-MNIONDOCSA-N)
Structure
SMILES
OS(=O)(=O)O.CN[C@H]([C@H](c1ccccc1)O)C.CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1
Molecular Formula:
C32H40ClN3O7S
Molecular Weight:
646.194
Log P:
6.9725
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
4
TPSA:
157.67
CAS Number(s):
156098-07-6
Synonym(s)
1.
Loratadine and pseudoephedrine sulfate
External Link(s)
PubChem Compound9917507
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 624US FAERS
2Product use issueFAERS: 141US FAERS
3SomnolenceFAERS: 129US FAERS
4Feeling jitteryFAERS: 80US FAERS
5DizzinessFAERS: 69US FAERS
6Feeling abnormalFAERS: 69US FAERS
7PalpitationsFAERS: 68US FAERS
8HeadacheFAERS: 65US FAERS
9Drug effect delayedFAERS: 63US FAERS
10Unevaluable eventFAERS: 56US FAERS
11NauseaFAERS: 39US FAERS
12OverdoseFAERS: 39US FAERS
13Therapeutic response unexpectedFAERS: 39US FAERS
14Drug effect incompleteFAERS: 37US FAERS
15NervousnessFAERS: 36US FAERS
16Poor quality sleepFAERS: 33US FAERS
17Extra dose administeredFAERS: 31US FAERS
18Product use in unapproved indicationFAERS: 31US FAERS
19Expired product administeredFAERS: 29US FAERS
20FatigueFAERS: 29US FAERS
21Wrong technique in product usage processFAERS: 26US FAERS
22AnxietyFAERS: 24US FAERS
23MalaiseFAERS: 24US FAERS
24Accidental overdoseFAERS: 23US FAERS
25DysuriaFAERS: 21US FAERS
26HypersensitivityFAERS: 21US FAERS
27TremorFAERS: 21US FAERS
28Accidental exposure to product by childFAERS: 19US FAERS
29Inappropriate schedule of drug administrationFAERS: 18US FAERS
30Incorrect dose administeredFAERS: 16US FAERS
31Incorrect drug administration durationFAERS: 16US FAERS
32VomitingFAERS: 16US FAERS
33Abdominal discomfortFAERS: 15US FAERS
34Initial insomniaFAERS: 15US FAERS
35ThirstFAERS: 15US FAERS
36ConstipationFAERS: 14US FAERS
37RestlessnessFAERS: 14US FAERS
38Drug ineffective for unapproved indicationFAERS: 13US FAERS
39Circumstance or information capable of leading to medication errorFAERS: 11US FAERS
40PruritusFAERS: 11US FAERS
41Drug screen positiveFAERS: 10US FAERS
42Incorrect product administration durationFAERS: 10US FAERS
43Adverse eventFAERS: 9US FAERS
44Drug DependenceFAERS: 9US FAERS
45SneezingFAERS: 9US FAERS
46Urinary RetentionFAERS: 9US FAERS
47Back PainFAERS: 8US FAERS
48Chest PainFAERS: 8US FAERS
49Chest discomfortFAERS: 8US FAERS
50DiscomfortFAERS: 8US FAERS
51DisorientationFAERS: 8US FAERS
52UrticariaFAERS: 8US FAERS
53AgitationFAERS: 7US FAERS
54AstheniaFAERS: 7US FAERS
55ChillsFAERS: 7US FAERS
56DehydrationFAERS: 7US FAERS
57Euphoric moodFAERS: 7US FAERS
58Oropharyngeal painFAERS: 7US FAERS
59PainFAERS: 7US FAERS
60Throat irritationFAERS: 7US FAERS
61DysgeusiaFAERS: 6US FAERS
62Head discomfortFAERS: 6US FAERS
63Product taste abnormalFAERS: 6US FAERS
64Lip swellingFAERS: 5US FAERS
65Middle insomniaFAERS: 5US FAERS
66NasopharyngitisFAERS: 5US FAERS
67Pharmaceutical product complaintFAERS: 5US FAERS
68Product prescribing issueFAERS: 5US FAERS
69SyncopeFAERS: 5US FAERS
70Therapeutic response changedFAERS: 5US FAERS
71Wrong technique in drug usage processFAERS: 5US FAERS
72Abdominal PainFAERS: 4US FAERS
73Accidental exposure to productFAERS: 4US FAERS
74Amphetamines positiveFAERS: 4US FAERS
75AngerFAERS: 4US FAERS
76CryingFAERS: 4US FAERS
77Depressed moodFAERS: 4US FAERS
78EpistaxisFAERS: 4US FAERS
79ErythemaFAERS: 4US FAERS
80Expired drug administeredFAERS: 4US FAERS
81HypervigilanceFAERS: 4US FAERS
82Myocardial InfarctionFAERS: 4US FAERS
83Nasal discomfortFAERS: 4US FAERS
84No adverse eventFAERS: 4US FAERS
85SluggishnessFAERS: 4US FAERS
86AnosmiaFAERS: 3US FAERS
87AsthmaFAERS: 3US FAERS
88Bladder painFAERS: 3US FAERS
89Cardiac FlutterFAERS: 3US FAERS
90Drug administration errorFAERS: 3US FAERS
91Drug prescribing errorFAERS: 3US FAERS
92Drug screen false positiveFAERS: 3US FAERS
93Erectile dysfunctionFAERS: 3US FAERS
94Failure of child resistant mechanism for pharmaceutical productFAERS: 3US FAERS
95Hypoaesthesia facialFAERS: 3US FAERS
96Medication ErrorFAERS: 3US FAERS
97Patient dissatisfaction with treatmentFAERS: 3US FAERS
98Product label issueFAERS: 3US FAERS
99Product packaging issueFAERS: 3US FAERS
100Product quality issueFAERS: 3US FAERS
101Product substitution issueFAERS: 3US FAERS
102Respiratory tract congestionFAERS: 3US FAERS
103RetchingFAERS: 3US FAERS
104SinusitisFAERS: 3US FAERS
105TachycardiaFAERS: 3US FAERS
106Therapeutic product ineffectiveFAERS: 3US FAERS
107TinnitusFAERS: 3US FAERS
108Activities of daily living impairedFAERS: 2US FAERS
109AgeusiaFAERS: 2US FAERS
110AlopeciaFAERS: 2US FAERS
111AnorexiaFAERS: 2US FAERS
112AphasiaFAERS: 2US FAERS
113AsthenopiaFAERS: 2US FAERS
114Bipolar DisorderFAERS: 2US FAERS
115Blood glucose increasedFAERS: 2US FAERS
116Burning sensationFAERS: 2US FAERS
117ChokingFAERS: 2US FAERS
118Cold sweatFAERS: 2US FAERS
119Drug administered to patient of inappropriate ageFAERS: 2US FAERS
120Drug effective for unapproved indicationFAERS: 2US FAERS
121Dry skinFAERS: 2US FAERS
122DysarthriaFAERS: 2US FAERS
123DyspepsiaFAERS: 2US FAERS
124DysphoniaFAERS: 2US FAERS
125Eyelid painFAERS: 2US FAERS
126FlatulenceFAERS: 2US FAERS
127LethargyFAERS: 2US FAERS
128Maternal exposure during pregnancyFAERS: 2US FAERS
129PallorFAERS: 2US FAERS
130Paranasal sinus hypersecretionFAERS: 2US FAERS
131PolydipsiaFAERS: 2US FAERS
132PresyncopeFAERS: 2US FAERS
133Product physical issueFAERS: 2US FAERS
134Productive CoughFAERS: 2US FAERS
135Renal painFAERS: 2US FAERS
136RhinalgiaFAERS: 2US FAERS
137StressFAERS: 2US FAERS
138Suicide attemptFAERS: 2US FAERS
139Tension HeadacheFAERS: 2US FAERS
140Toxicity to various agentsFAERS: 2US FAERS
141Urinary tract infectionFAERS: 2US FAERS
142Accidental drug intake by childFAERS: 1US FAERS
143Accidental exposure to product packaging by childFAERS: 1US FAERS
144AcneFAERS: 1US FAERS
145Administration site drynessFAERS: 1US FAERS
146AmnesiaFAERS: 1US FAERS
147Anal FissureFAERS: 1US FAERS
148Angina PectorisFAERS: 1US FAERS
149AngioedemaFAERS: 1US FAERS
150AnuriaFAERS: 1US FAERS
151AutopsyFAERS: 1US FAERS
152Bladder dysfunctionFAERS: 1US FAERS
153BlindnessFAERS: 1US FAERS
154Blood alcohol increasedFAERS: 1US FAERS
155Blood creatinine increasedFAERS: 1US FAERS
156Blood urea increasedFAERS: 1US FAERS
157BoredomFAERS: 1US FAERS
158Breast discomfortFAERS: 1US FAERS
159BruxismFAERS: 1US FAERS
160CataractFAERS: 1US FAERS
161Cerebrovascular accidentFAERS: 1US FAERS
162Contraindicated drug administeredFAERS: 1US FAERS
163Counterfeit drug administeredFAERS: 1US FAERS
164CyanosisFAERS: 1US FAERS
165Depressed Level of ConsciousnessFAERS: 1US FAERS
166Dermatitis HerpetiformisFAERS: 1US FAERS
167DiplopiaFAERS: 1US FAERS
168Drug abuseFAERS: 1US FAERS
169Drug chemical incompatibilityFAERS: 1US FAERS
170Drug dispensing errorFAERS: 1US FAERS
171Drug resistanceFAERS: 1US FAERS
172Drug withdrawal headacheFAERS: 1US FAERS
173Drug withdrawal syndromeFAERS: 1US FAERS
174Drug-disease interactionFAERS: 1US FAERS
175EczemaFAERS: 1US FAERS
176Facial PainFAERS: 1US FAERS
177Feeling ColdFAERS: 1US FAERS
178Flank PainFAERS: 1US FAERS
179FlushingFAERS: 1US FAERS
180FormicationFAERS: 1US FAERS
181Genital erythemaFAERS: 1US FAERS
182HemiplegiaFAERS: 1US FAERS
183HungerFAERS: 1US FAERS
184Impaired driving abilityFAERS: 1US FAERS
185IncoherentFAERS: 1US FAERS
186Incorrect route of product administrationFAERS: 1US FAERS
187Increased upper airway secretionFAERS: 1US FAERS
188Intentional product misuseFAERS: 1US FAERS
189Joint stiffnessFAERS: 1US FAERS
190LacerationFAERS: 1US FAERS
191Limb discomfortFAERS: 1US FAERS
192Loss of personal independence in daily activitiesFAERS: 1US FAERS
193Medication residue presentFAERS: 1US FAERS
194Memory impairmentFAERS: 1US FAERS
195Mental impairmentFAERS: 1US FAERS
196MonoplegiaFAERS: 1US FAERS
197Mood swingsFAERS: 1US FAERS
198Muscle tightnessFAERS: 1US FAERS
199MyalgiaFAERS: 1US FAERS
200Nasal pruritusFAERS: 1US FAERS
201NegativismFAERS: 1US FAERS
202NocturiaFAERS: 1US FAERS
203OliguriaFAERS: 1US FAERS
204Ophthalmological examination abnormalFAERS: 1US FAERS
205Oral pruritusFAERS: 1US FAERS
206Oropharyngeal discomfortFAERS: 1US FAERS
207Paranasal sinus discomfortFAERS: 1US FAERS
208Patient uncooperativeFAERS: 1US FAERS
209PoisoningFAERS: 1US FAERS
210Post-Traumatic Stress DisorderFAERS: 1US FAERS
211Pre-existing condition improvedFAERS: 1US FAERS
212Premature EjaculationFAERS: 1US FAERS
213Product blister packaging issueFAERS: 1US FAERS
214Product counterfeitFAERS: 1US FAERS
215Product package associated injuryFAERS: 1US FAERS
216Product physical consistency issueFAERS: 1US FAERS
217Product preparation issueFAERS: 1US FAERS
218Product shape issueFAERS: 1US FAERS
219Product size issueFAERS: 1US FAERS
220Product solubility abnormalFAERS: 1US FAERS
221Product use complaintFAERS: 1US FAERS
222ProstatismFAERS: 1US FAERS
223Rebound effectFAERS: 1US FAERS
224Secondary hypertensionFAERS: 1US FAERS
225Sexual DysfunctionFAERS: 1US FAERS
226Sinus headacheFAERS: 1US FAERS
227Skin irritationFAERS: 1US FAERS
228SunburnFAERS: 1US FAERS
229Suprapubic painFAERS: 1US FAERS
230SwellingFAERS: 1US FAERS
231TachyphreniaFAERS: 1US FAERS
232Temperature regulation disorderFAERS: 1US FAERS
233TensionFAERS: 1US FAERS
234Therapeutic product effective for unapproved indicationFAERS: 1US FAERS
235Therapy cessationFAERS: 1US FAERS
236Upper respiratory tract congestionFAERS: 1US FAERS
237Upper-airway cough syndromeFAERS: 1US FAERS
238Urethritis noninfectiveFAERS: 1US FAERS
239Urinary IncontinenceFAERS: 1US FAERS
240VasculitisFAERS: 1US FAERS
241VertigoFAERS: 1US FAERS
242Viral upper respiratory tract infectionFAERS: 1US FAERS
243Visual ImpairmentFAERS: 1US FAERS
244Weight decreasedFAERS: 1US FAERS
245WheezingFAERS: 1US FAERS
246White blood cell count decreasedFAERS: 1US FAERS
247Wrong doseFAERS: 1US FAERS
248Wrong drug administeredFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.